Rare disease news, mapped to the diseases behind the headlines. AI-classified across pipeline, policy, funding, science, and community.
Be among the first to receive Kisho Intelligence Briefings
Showing news related to
Showing 1–2 of 2 stories
A study demonstrates successful reduced-intensity cord blood transplantation in infants with familial hemophagocytic lymphohistiocytosis type 2. This approach may improve treatment outcomes for affected infants.
Read full storyA novel homozygous PRF1 variant has been identified as a cause of atypical familial hemophagocytic lymphohistiocytosis in patients with severe COVID-19. This discovery enhances understanding of the genetic factors contributing to this rare disease.
Get the week's most important rare disease developments — pipeline moves, policy changes, and funding signals — delivered to your inbox every Monday.
Free weekly briefing. Unsubscribe anytime.